Sanara MedTech Inc. Announces Merger Agreement with MiMedx

What Happened
Sanara MedTech Inc. filed an amendment to its Form 8‑K on August 11, 2026, relating to a Merger Agreement dated July 29, 2026 among Sanara MedTech Inc., MiMedx Group, Inc. and Mustang Merger Sub, Inc. The company attached the Merger Agreement and a related Voting Agreement and issued a press release on July 29, 2026 announcing the transaction. The amendment corrects previously reported termination‑fee figures: the correct termination fee payable by Sanara MedTech in certain circumstances is $9,660,336.00, and the correct termination fee payable by MiMedx Group, Inc. in certain circumstances is $22,540,785.00. The filing states that, except for these corrections, no other disclosures in the original report are amended or updated.

Key Details

• Merger Agreement and Voting Agreement dated July 29, 2026 (Exhibits 2.1 and 10.1).
• Press release announcing the merger issued July 29, 2026 (Exhibit 99.1).
• Corrected termination fees: Sanara MedTech — $9,660,336.00; MiMedx Group, Inc. — $22,540,785.00.
• Amendment does not update events after the original report and leaves other disclosures unchanged.

Why It Matters
This filing confirms a definitive merger agreement has been entered and provides corrected figures for termination fees, which are material to understanding the potential costs or penalties if the deal is not completed. Investors should note the corrected dollar amounts when assessing deal risk and potential financial exposure. Watch for subsequent SEC filings (e.g., proxy statements, shareholder votes, regulatory notices) for transaction terms, timing and any impact on shares or company finances.